Autoimmune diseases and malignant tumors are the two hotspots and difficulties that are currently being studied and concerned by the medical field. The use of PD-1/PD-L1 inhibitors improves the prognosis of advanced tumors. but excessive immune responses can also induce immune-related adverse events (irAEs). Due to this concern. https://hollandscountryclothinges.shop/product-category/balaclavas/